Clinical Trial Update: Akkermansia Muciniphila Combined With Infliximab for Promoting Intestinal Mucosal Healing in Crohn's Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating whether combining Akkermansia muciniphila with infliximab can promote intestinal mucosal healing in Crohn's disease; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Akkermansia muciniphila (Akkermansia muciniphila)
• Remicade (infliximab)

Snippet

Sponsor: Chinese Medical Association | Conditions: Crohn's Diseases | Phase 4 | Status: NOT_YET_RECRUITING